Response Oncology, Inc. (ROIX) Stock
Response Oncology, Inc., originally incorporated in Memphis, Tennessee, in 1984, has largely ceased its business activities and no longer maintains significant operations. By May 20, 2002, the company had completed the liquidation of most of its operating assets, with the expectation that all remaining assets would be sold and wind-down procedures finalized by the end of that year.
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Peer Comparison
About Response Oncology, Inc.
Response Oncology, Inc., originally incorporated in Memphis, Tennessee, in 1984, has largely ceased its business activities and no longer maintains significant operations. By May 20, 2002, the company had completed the liquidation of most of its operating assets, with the expectation that all remaining assets would be sold and wind-down procedures finalized by the end of that year. Historically, the company functioned as a comprehensive cancer management firm, providing advanced cancer treatment through its outpatient IMPACT Centers, overseeing the non-medical aspects of oncology practices, compounding and dispensing pharmaceuticals to specific oncologists, and conducting outcomes research for pharmaceutical manufacturers.
Response Oncology, Inc. (ROIX) stock trades at $0.00 with a market capitalization of $12.